Prostate cancer natural history, complications and prognosis: Difference between revisions
No edit summary |
|||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{CMG}} | {{CMG}} | ||
{{Prostate cancer}} | {{Prostate cancer}} {{AE}} {{sali}} | ||
==Overview== | ==Overview== | ||
Revision as of 17:58, 20 February 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
|
Prostate cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Prostate cancer natural history, complications and prognosis On the Web |
|
American Roentgen Ray Society Images of Prostate cancer natural history, complications and prognosis |
|
FDA on Prostate cancer natural history, complications and prognosis |
|
CDC on Prostate cancer natural history, complications and prognosis |
|
Prostate cancer natural history, complications and prognosis in the news |
|
Blogs on Prostate cancer natural history, complications and prognosis |
|
Risk calculators and risk factors for Prostate cancer natural history, complications and prognosis |
Associate Editor(s)-in-Chief: Syed Musadiq Ali M.B.B.S.[2]
Overview
Prognosis of prostate cancer is generally good, and the 5-year survival rate is approximately 98.9%. The prognosis varies with the stage of tumor; Localized and regional tumors have the most favorable prognosis.
Prognosis
- Between 2004 and 2010, the 5-year relative survival of patients with prostate cancer was 98.9%.[1]
- When stratified by age, the 5-year relative survival of patients with prostate cancer was 99.1% and 98.8% for patients <65 and ≥ 65 years of age respectively.[1]
- The survival of patients with prostate cancer varies with the stage of the disease. Shown below is a table depicting the 5-year relative survival by the stage of prostate cancer:[1]
| Stage | 5-year relative survival (%), (2004-2010) |
| All stages | 98.9% |
| Localized | 100% |
| Regional | 100% |
| Distant | 28% |
| Unstaged | 73.9% |
- Shown below is an image depicting the 5-year conditional relative survival (probability of surviving in the next 5-years given the cohort has already survived 0, 1, 3 years) between 2004 and 2010 of prostate cancer by stage at diagnosis according to SEER. These graphs are adapted from SEER: The Surveillance, Epidemiology, and End Results Program of the National Cancer Institute.[1]
References
- ↑ 1.0 1.1 1.2 1.3 Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.